Tag Archives: EXEL

Top 5 Warren Buffett Stocks To Buy Right Now

Billionaire investor Warren Buffett said Monday he was close to making a big acquisition in the fourth quarter, but it fell apart.

“We had at least one deal possible that would have been very large,” Buffett told CNBC’s Becky Quick from Berkshire-owned Nebraska Furniture Mart on Monday. “I liked stocks in the fourth quarter, but I would like buying a business even better.”

Buffett added that he didn’t think the deal was on the table any longer but did not say why not. When pressed for further details on the mystery deal, Buffett said, “I’ll give you a hint. It’s on this planet.”

The 88-year-old chairman and CEO of Berkshire Hathaway spoke from Omaha, Nebraska, after the release of the conglomerate’s annual shareholder letter this weekend. In the widely shared letter, Buffett said he wanted to make an acquisition, but prices “are sky-high for businesses possessing decent long-term prospects.”

Top 5 Warren Buffett Stocks To Buy Right Now: Physicians Realty Trust(DOC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Physicians Realty Trust (DOC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Physicians Realty Trust (NYSE:DOC) had its price target decreased by KeyCorp from $20.00 to $17.00 in a report issued on Tuesday, MarketBeat reports. KeyCorp currently has a buy rating on the real estate investment trust’s stock. KeyCorp also issued estimates for Physicians Realty Trust’s FY2018 earnings at $1.10 EPS and FY2019 earnings at $1.12 EPS.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Physicians Realty Trust (DOC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Warren Buffett Stocks To Buy Right Now: Limelight Networks Inc.(LLNW)

Advisors’ Opinion:

  • [By Motley Fool Transcribing]

    Limelight Networks (NASDAQ:LLNW) Q2 2018 Earnings Conference CallJul. 19, 2018 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Steve Symington]

    Shares of Limelight Networks Inc. (NASDAQ:LLNW) jumped 25.5% in April, according to data from S&P Global Market Intelligence, after the digital content-delivery specialist announced significantly stronger-than-expected first-quarter results.

  • [By Joseph Griffin]

    The Manufacturers Life Insurance Company boosted its position in shares of Limelight Networks, Inc. (NASDAQ:LLNW) by 18.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 71,533 shares of the information services provider’s stock after purchasing an additional 11,383 shares during the period. The Manufacturers Life Insurance Company owned about 0.06% of Limelight Networks worth $294,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Limelight Networks, Inc. (NASDAQ:LLNW) CEO Robert A. Lento sold 40,000 shares of the business’s stock in a transaction dated Tuesday, September 4th. The stock was sold at an average price of $4.89, for a total value of $195,600.00. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Top 5 Warren Buffett Stocks To Buy Right Now: Exelixis, Inc.(EXEL)

Advisors’ Opinion:

  • [By ]

    3 Biotech Standouts
    Founded in 1994 and a member of the S&P 400 Mid-Cap Index since last summer, Exelixis (Nasdaq: EXEL) has already brought three cancer therapies (Cabometyx and Cometriq for thyroid and kidney cancer, and Cotellic, approved for treating melanoma in combination with older drug vemurafenib) to the market. 

  • [By Shane Hupp]

    Old Mutual Global Investors UK Ltd. raised its holdings in Exelixis, Inc. (NASDAQ:EXEL) by 26.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,562,369 shares of the biotechnology company’s stock after purchasing an additional 747,398 shares during the quarter. Old Mutual Global Investors UK Ltd. owned 1.20% of Exelixis worth $78,906,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Wedbush Securities Inc. purchased a new position in shares of Exelixis (NASDAQ:EXEL) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 14,215 shares of the biotechnology company’s stock, valued at approximately $315,000.

  • [By Keith Speights, Sean Williams, and Brian Feroldi]

    We asked three Motley Fool contributors to pick the biotech stocks that they think provide great prospects of generating those solid returns that investors crave. Here’s why they chose Celgene (NASDAQ:CELG), Exelixis (NASDAQ:EXEL), and Xencor (NASDAQ:XNCR) as top biotech stocks to buy right now.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Exelixis (EXEL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Warren Buffett Stocks To Buy Right Now: NIC Inc.(EGOV)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on NIC (EGOV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    BidaskClub upgraded shares of NIC (NASDAQ:EGOV) from a buy rating to a strong-buy rating in a research note published on Friday morning.

    Several other research firms also recently commented on EGOV. Zacks Investment Research downgraded NIC from a hold rating to a sell rating in a report on Monday, January 8th. ValuEngine downgraded NIC from a sell rating to a strong sell rating in a report on Wednesday, May 2nd. Barrington Research restated a hold rating on shares of NIC in a report on Monday, April 30th. TheStreet downgraded NIC from a b- rating to a c rating in a report on Thursday, March 8th. Finally, Loop Capital decreased their price objective on NIC to $14.00 and set a hold rating for the company in a report on Friday, February 2nd. Two analysts have rated the stock with a sell rating, five have issued a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of Hold and a consensus target price of $18.33.

  • [By Joseph Griffin]

    Media headlines about NIC (NASDAQ:EGOV) have been trending somewhat positive recently, according to Accern Sentiment. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. NIC earned a media sentiment score of 0.05 on Accern’s scale. Accern also gave news headlines about the software maker an impact score of 44.2220263592641 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Top 5 Warren Buffett Stocks To Buy Right Now: Penns Woods Bancorp, Inc.(PWOD)

Advisors’ Opinion:

  • [By Shane Hupp]

    Headlines about Penns Woods Bancorp (NASDAQ:PWOD) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Penns Woods Bancorp earned a news impact score of 0.04 on Accern’s scale. Accern also gave news coverage about the financial services provider an impact score of 46.2338385861856 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Best Value Stocks To Invest In Right Now

&l;p&g;Life insurance is a fundamental risk management tool for a secure financial lifestyle. Primarily, it functions as an income replacement insurance product during an individual&a;rsquo;s working years. In many cases, life insurance is set up to provide financial security for family members or to pay off liabilities in the event of an untimely and premature death. Because the likelihood of the death of the insured occurring during working years is relatively low, but the impact would be devastating, insurance is a perfect fit for the situation. However, many people not only buy term insurance, but they also buy a permanent life insurance product. Permanent life insurance is different than term insurance as it offers the potential of an investment component or cash value in addition to life insurance coverage. Because these insurance products will last for life, past your working years and through retirement, it is important to think about permanent products as assets that can also help support a secure retirement.

Best Value Stocks To Invest In Right Now: Exelixis, Inc.(EXEL)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Tuesday was an upbeat day on Wall Street — the Dow Jones Industrials climbed more than 100 points, and other major market indexes posted gains of around half a percent. A strong economy and optimism about the upcoming earnings results for the third-quarter have helped boost market confidence over the past month, and even issues like tariff disputes and the midterm elections haven’t been enough to push the key stock indexes far off their record highs. Yet even though investors were in a good mood generally Tuesday, company-specific bad news sent some shares lower. SandRidge Energy (NYSE:SD), Sonos (NASDAQ:SONO), and Exelixis (NASDAQ:EXEL) were among the worst performers on the day. Below, we’ll look more closely at these companies to tell you why their shares did so poorly.

  • [By ]

    Another biotech worth  considering is Exelixis Inc. (NASDAQ: EXEL).

    The company recently received FDA approval of a new cancer treatment that according to a recent NASDAQ industry report “should further boost demand” and send share values higher.

  • [By Paul Ausick]

    Exelixis Inc. (NASDAQ: EXEL) traded down about 4.4% Tuesday to post a new 52-week low of $16.92 after closing Monday at $17.69. The stock’s 52-week high is $32.50. Volume was 25% below the daily average of about 4.2 million shares. The company had no specific news and shares have recovered enough to get on track for a daily gain of around 1%.

  • [By Max Byerly]

    Shares of Exelixis, Inc. (NASDAQ:EXEL) have received a consensus recommendation of “Buy” from the sixteen research firms that are covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a sell recommendation, two have given a hold recommendation, nine have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $30.70.

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    With that in mind, we asked a team of Motley Fool investors to highlight a biotech stock that they think is a strong buy right now. Here’s why they picked Exelixis (NASDAQ:EXEL), Celgene (NASDAQ:CELG), and Ionis Pharmaceuticals (NASDAQ:IONS). 

  • [By Stephan Byrd]

    Exelixis, Inc. (NASDAQ:EXEL) VP Patrick J. Haley sold 3,663 shares of the business’s stock in a transaction dated Friday, May 18th. The stock was sold at an average price of $21.61, for a total transaction of $79,157.43. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Best Value Stocks To Invest In Right Now: Resolute Energy Corporation(REN )

Advisors’ Opinion:

  • [By Ethan Ryder]

    Shares of Resolute Energy Corp (NYSE:REN) have received an average rating of “Hold” from the nine ratings firms that are currently covering the firm, Marketbeat reports. Seven analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $39.17.

  • [By Max Byerly]

    Republic Protocol (CURRENCY:REN) traded 15% lower against the U.S. dollar during the one day period ending at 16:00 PM E.T. on June 23rd. Over the last week, Republic Protocol has traded down 25.4% against the U.S. dollar. One Republic Protocol token can now be purchased for approximately $0.0590 or 0.00000961 BTC on popular cryptocurrency exchanges including OKEx, IDEX, DDEX and Cobinhood. Republic Protocol has a market capitalization of $32.57 million and $2.71 million worth of Republic Protocol was traded on exchanges in the last 24 hours.

  • [By Shane Hupp]

    Republic Protocol (CURRENCY:REN) traded 8.6% lower against the dollar during the 1-day period ending at 12:00 PM E.T. on June 13th. Republic Protocol has a total market capitalization of $39.37 million and $1.56 million worth of Republic Protocol was traded on exchanges in the last 24 hours. Over the last week, Republic Protocol has traded 22.7% lower against the dollar. One Republic Protocol token can now be purchased for $0.0757 or 0.00001210 BTC on popular exchanges including Cobinhood, IDEX, DDEX and Liqui.

Best Value Stocks To Invest In Right Now: MoSys, Inc.(MOSY)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading.
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading.
    Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading.
    Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading.
    MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading.
    Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan.
    Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading.
    MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading.
    Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results.
    Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading.
    Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings.
    Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.

     

  • [By Money Morning Staff Reports]

    That’s why today we’ll show you one of our expert recommendations along with the 10 top-performing penny stocks to watch this week…

    Penny Stocks Current Share Price
    (as of Feb. 20) Feb. 12-20 Gain
    (as of Feb. 20)
    POET Technologies Inc. (OTCMKTS: POETF) $0.4165 85.1%
    Finjan Holdings Inc. (Nasdaq: FNJN) $2.94 67.05%
    Intelsat SA (NYSE: I) $3.50 38.89%
    Genesis Healthcare Inc. (NYSE: GEN) $1.39 37.62%
    Paringa Resources Ltd. (OTCMKTS: PNGZF) $0.41 32.30%
    CytoDyn Inc. (OTCMKTS: CYDY) $0.76 31.03%
    Iconix Brand Group Inc. (Nasdaq: ICON) $1.65 30.95%
    AMERI Holdings Inc. (Nasdaq: AMRH) $2.49 29.69%
    Pangea Logistics Solutions Ltd. (Nasdaq: PANL) $2.87 26.99%
    MoSys Inc. (Nasdaq: MOSY) $1.47 25.68%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Lisa Levin]

    MoSys, Inc. (NASDAQ: MOSY) shares were also up, gaining 27 percent to $1.9265 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.

  • [By Lisa Levin]

    MoSys, Inc. (NASDAQ: MOSY) shares were also up, gaining 21 percent to $1.84 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.

Best Value Stocks To Invest In Right Now: Immunomedics, Inc.(IMMU)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Celldex Therapeutics (NASDAQ: CLDX) and Immunomedics (NASDAQ:IMMU) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings.

  • [By Logan Wallace]

    Immunomedics, Inc. (NASDAQ:IMMU) Director Venbio Select Advisor Llc bought 575,000 shares of the company’s stock in a transaction on Friday, June 15th. The stock was bought at an average cost of $24.00 per share, for a total transaction of $13,800,000.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Max Byerly]

    Swiss National Bank cut its holdings in Immunomedics, Inc. (NASDAQ:IMMU) by 4.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 203,050 shares of the biopharmaceutical company’s stock after selling 8,600 shares during the period. Swiss National Bank’s holdings in Immunomedics were worth $4,806,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Immunomedics (IMMU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Maxx Chatsko]

    Shares of Immunomedics (NASDAQ:IMMU) rose nearly 12% last month, according to data provided by S&P Global Market Intelligence. The $5 billion biopharma announced fiscal first-quarter and full-year 2018 financial results, although as a pre-commercial company, investors were more interested in the business updates provided. 

  • [By Todd Campbell]

    After unveiling positive results for its lead drug, sacituzumab govitecan, in breast cancer at the influential American Society of Clinical Oncology (ASCO) conference, shares in Immunomedics (NASDAQ:IMMU) rallied by as much as 14.7% today before settling in for a gain of 9.3% at 3 p.m. EDT.

Best Value Stocks To Invest In Right Now: United States Steel Corporation(X)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Commerzbank Aktiengesellschaft FI trimmed its holdings in shares of U.S. Steel (NYSE:X) by 3.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 121,345 shares of the basic materials company’s stock after selling 4,606 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in U.S. Steel were worth $4,270,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Shares of TMX Group Ltd (TSE:X) have been assigned a consensus rating of “Buy” from the six ratings firms that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is C$90.33.

  • [By ]

    United States Steel (X) : “We’ve got Nucor (NUE) and that’s the one you want to buy.”

    Del Taco Restaurants (TACO) : “We have so many others in that group, why go with this one?”

Best Value Stocks To Invest In Right Now: Wabash National Corporation(WNC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Wabash National Co. (NYSE:WNC) shares reached a new 52-week low on Friday . The company traded as low as $17.91 and last traded at $18.09, with a volume of 33824 shares trading hands. The stock had previously closed at $18.51.

  • [By Tyler Crowe]

    It wasn’t that long ago that concerns about a downturn in the truck trailer business had investors concerned that Wabash National’s (NYSE:WNC) best days were behind it. Those concerns seem to have been overblown, though, as demand for Wabash’s products were high enough for management to raise its sales guidance for the year. 

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Wabash National (WNC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Wabash National (WNC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Wabash National (WNC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks To Watch Right Now

There’s a veritable hurricane of events–not to mention an actual hurricane–that should be rocking the market–but stocks barely moved today as investors wait for the U.S. payrolls data tomorrow.

Getty Images

The S&P 500 ticked up 0.1% to 2,160.77 today, while the Dow Jones Industrial Average dipped 12.53 points, or 0.1%, to 18,268.50. The Nasdaq Composite declined 0.2% to 5,306.85.

Rhino Trading’s Michael Block considers the market’s lack of action:

…global markets continue to stumble around in a tight band, unable to break out or just plain break, it seems. Yesterday we saw a nice rally driven by bullish oil inventories and talk of an OPEC meeting before the meeting next week. That was undone by chatter that the German government was seeking discreet talks with the U.S. authorities on Deutsche Bank (DB). Thats code for they need to fix that before everyone gets sick, and fixing things means short term pain.

Top 5 Heal Care Stocks To Watch Right Now: OSI Systems, Inc.(OSIS)

Advisors’ Opinion:

  • [By Shane Hupp]

    Here are some of the headlines that may have impacted Accern’s rankings:

    Get OSI Systems alerts:

    OSI Systems (OSIS) Rating Increased to Buy at Zacks Investment Research (americanbankingnews.com) OSI Systems (OSIS) Downgraded by BidaskClub (americanbankingnews.com) OSI Systems (OSIS) Downgraded by Zacks Investment Research to Hold (americanbankingnews.com) $274.42 Million in Sales Expected for OSI Systems, Inc. (OSIS) This Quarter (americanbankingnews.com) Zacks: Analysts Expect OSI Systems, Inc. (OSIS) Will Post Earnings of $0.94 Per Share (americanbankingnews.com)

    OSIS has been the subject of several research reports. Sidoti initiated coverage on OSI Systems in a research note on Wednesday, February 21st. They issued a “buy” rating for the company. Zacks Investment Research raised OSI Systems from a “hold” rating to a “buy” rating and set a $69.00 price objective for the company in a research note on Wednesday, April 4th. ValuEngine lowered OSI Systems from a “hold” rating to a “sell” rating in a research note on Wednesday, May 2nd. Jefferies Group lowered OSI Systems from a “buy” rating to a “hold” rating and dropped their price objective for the company from $79.00 to $70.00 in a research note on Friday, February 2nd. They noted that the move was a valuation call. Finally, BidaskClub lowered OSI Systems from a “sell” rating to a “strong sell” rating in a research note on Saturday, January 20th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $86.20.

  • [By Logan Wallace]

    Millennium Management LLC lessened its stake in shares of OSI Systems, Inc. (NASDAQ:OSIS) by 40.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 255,483 shares of the technology company’s stock after selling 170,680 shares during the quarter. Millennium Management LLC owned about 1.41% of OSI Systems worth $16,675,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on OSI Systems (OSIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks To Watch Right Now: Iridium Communications Inc(IRDM)

Advisors’ Opinion:

  • [By Max Byerly]

    Iridium Communications (NASDAQ: IRDM) and Inseego (NASDAQ:INSG) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, risk and profitability.

  • [By Logan Wallace]

    Gargoyle Investment Advisor L.L.C. cut its holdings in Iridium Communications Inc (NASDAQ:IRDM) by 16.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 23,251 shares of the technology company’s stock after selling 4,500 shares during the period. Gargoyle Investment Advisor L.L.C.’s holdings in Iridium Communications were worth $262,000 as of its most recent filing with the SEC.

  • [By Joseph Griffin]

    Iridium Communications (NASDAQ: IRDM) and AAC TECHNOLOGIE/ADR (OTCMKTS:AACAY) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation.

  • [By Max Byerly]

    Prudential Financial Inc. decreased its holdings in shares of Iridium Communications Inc (NASDAQ:IRDM) by 6.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,187,699 shares of the technology company’s stock after selling 75,910 shares during the period. Prudential Financial Inc. owned approximately 1.08% of Iridium Communications worth $13,361,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Iridium Communications (IRDM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks To Watch Right Now: U.S. Physical Therapy, Inc.(USPH)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks To Watch Right Now: Exelixis, Inc.(EXEL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Old Mutual Global Investors UK Ltd. raised its holdings in Exelixis, Inc. (NASDAQ:EXEL) by 26.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,562,369 shares of the biotechnology company’s stock after purchasing an additional 747,398 shares during the quarter. Old Mutual Global Investors UK Ltd. owned 1.20% of Exelixis worth $78,906,000 as of its most recent SEC filing.

  • [By ]

    Another biotech worth considering is Exelixis Inc. (NASDAQ: EXEL).

    The company recently received FDA approval of a new cancer treatment that according to a recent NASDAQ industry report should further boost demand and send share values higher.

  • [By Stephan Byrd]

    Wedbush Securities Inc. purchased a new position in shares of Exelixis (NASDAQ:EXEL) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 14,215 shares of the biotechnology company’s stock, valued at approximately $315,000.

Top 5 Heal Care Stocks To Watch Right Now: Coeur d’Alene Mines Corporation(CDE)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Coeur Mining Inc (NYSE:CDE) – Equities researchers at Cormark lifted their Q2 2018 earnings estimates for Coeur Mining in a note issued to investors on Tuesday, July 10th. Cormark analyst R. Gray now anticipates that the basic materials company will earn ($0.02) per share for the quarter, up from their previous estimate of ($0.05). Cormark also issued estimates for Coeur Mining’s Q3 2018 earnings at $0.02 EPS, Q4 2018 earnings at $0.07 EPS, FY2018 earnings at $0.07 EPS, Q1 2019 earnings at $0.15 EPS, Q2 2019 earnings at $0.15 EPS, Q3 2019 earnings at $0.15 EPS, Q4 2019 earnings at $0.15 EPS and FY2019 earnings at $0.60 EPS.

  • [By Reuben Gregg Brewer]

    There’s no way to sugarcoat it:2017 was not a particularly good year for shareholders of silver and gold miner Coeur Mining, Inc. (NYSE:CDE). When it comes to investing, though, you need to balance the past with the future, and this miner’s efforts in 2017 look like they will set up a much better long-term future. Here’s why precious metals investors should be taking a closer look at Coeur Mining, but probably shouldn’t rush to pull the trigger.

  • [By Shane Hupp]

    Franco Nevada (NYSE: FNV) and Coeur Mining (NYSE:CDE) are both basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk and institutional ownership.

Top 10 Gold Stocks For 2019

Gerardo Del Real, a leading metals and mining expert, recently launched the Resource Stock Digest. In December, he had rare opportunity to interview the legendary James Dines.

Gerardo Del Real: This is Gerardo Del Real for Resource Stock Digest. I have a real treat for you today. Joining me today is the legendary Mr. James Dines. Mr. Dines is the editor of The Dines Letter. He’s also authored several books including Goldbug!, Technical Analysis, Secrets of High States, and Mass Psychology.

Mr. Dines has a legendary record in the investment community. His contrarian approach to investment analysis has led Mr. Dines to accurately forecast trends for many decades, from the unexpected gold boom of 1974, to the internet revolution of 1996, Mr. Dines has consistently gone against the grain and delivered gains that have been passed down for generations.

Top 10 Gold Stocks For 2019: Exelixis, Inc.(EXEL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Old Mutual Global Investors UK Ltd. raised its holdings in Exelixis, Inc. (NASDAQ:EXEL) by 26.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,562,369 shares of the biotechnology company’s stock after purchasing an additional 747,398 shares during the quarter. Old Mutual Global Investors UK Ltd. owned 1.20% of Exelixis worth $78,906,000 as of its most recent SEC filing.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    MDC Partners Inc. (NASDAQ: MDCA) fell 23.4 percent to $5.25 in pre-market trading after a first-quarter earnings miss.
    Hudson Technologies Inc. (NASDAQ: HDSN) shares fell 15.1 percent to $3.48 in pre-market trading after the company reported downbeat Q1 earnings.
    Nuance Communications, Inc. (NASDAQ: NUAN) fell 14 percent to $13.15 in pre-market trading after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance.
    Myomo, Inc. (NYSE: MYO) fell 13.2 percent to $3.10 in pre-market trading after reporting downbeat quarterly results.
    Rowan Companies plc (NYSE: RDC) shares fell 10.7 percent to $14.13 in pre-market trading after climbing 8.50 percent on Wednesday.
    BT Group plc (NYSE: BT) fell 9 percent to $14.80 in pre-market trading after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years.
    Exelixis, Inc. (NASDAQ: EXEL) fell 8.3 percent to $19.90 in pre-market trading after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint.
    Infinera Corporation (NASDAQ: INFN) fell 8.2 percent to $10.80 in pre-market trading after reporting Q1 results.
    Synaptics, Incorporated (NASDAQ: SYNA) shares fell 7.4 percent to $43.00 in pre-market trading. Synaptics reported better-than-expected earnings for its third quarter, while sales missed estimates.
    Randgold Resources Limited (NASDAQ: GOLD) shares fell 7.4 percent to $76.23 in pre-market trading after reporting Q1 earnings.
    Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares fell 7 percent to $59.36 in pre-market trading. Integra LifeSciences priced its 5.25 million share public offering of common stock at $58.50 per share.
    Array BioPharma Inc. (NASDAQ: ARRY) shares fell 6.9 percent to $12.75 in pre-m

  • [By Max Byerly]

    BidaskClub upgraded shares of Exelixis (NASDAQ:EXEL) from a strong sell rating to a sell rating in a report released on Friday.

    EXEL has been the subject of a number of other research reports. Cann restated a buy rating and set a $40.00 price objective on shares of Exelixis in a research note on Wednesday, May 30th. ValuEngine lowered Exelixis from a sell rating to a strong sell rating in a research note on Friday, May 11th. William Blair reaffirmed a buy rating on shares of Exelixis in a report on Wednesday, April 11th. Oppenheimer raised Exelixis from a market perform rating to an outperform rating and set a $40.00 target price on the stock in a report on Tuesday, February 27th. Finally, Stifel Nicolaus reduced their target price on Exelixis from $30.00 to $29.00 and set a hold rating on the stock in a report on Thursday, May 3rd. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and nine have issued a buy rating to the company’s stock. The company has a consensus rating of Hold and an average price target of $32.80.

Top 10 Gold Stocks For 2019: Rocky Mountain Chocolate Factory Inc.(RMCF)

Advisors’ Opinion:

  • [By Max Byerly]

    Rocky Mountain Chocolate Factory (NASDAQ: RMCF) and Tootsie Roll Industries (NYSE:TR) are both small-cap retail/wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

  • [By Ethan Ryder]

    Rocky Mountain Chocolate Factory (NASDAQ: RMCF) and Tootsie Roll Industries (NYSE:TR) are both small-cap retail/wholesale companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, dividends and analyst recommendations.

Top 10 Gold Stocks For 2019: EPAM Systems, Inc.(EPAM)

Advisors’ Opinion:

  • [By Logan Wallace]

    Schwab Charles Investment Management Inc. increased its position in EPAM Systems (NYSE:EPAM) by 4.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 360,326 shares of the information technology services provider’s stock after purchasing an additional 14,329 shares during the quarter. Schwab Charles Investment Management Inc.’s holdings in EPAM Systems were worth $41,265,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Dan Caplinger]

    Constant advances in technology require companies of all sizes to make efforts to keep up and take maximum advantage of new capabilities before competitors do. That puts companies like EPAM Systems (NYSE:EPAM) in a great position, because the resulting demand for IT services is constant and growing. EPAM did a good job of fulfilling its potential for strong growth in 2017, and the IT services specialist has high hopes that 2018 will bring even more gains.

  • [By Ethan Ryder]

    These are some of the media headlines that may have impacted Accern Sentiment’s scoring:

    Get EPAM Systems alerts:

    33 Top US Companies Short-Listed in 10 categories for USA-Europe Shared Services Awards, June 20th, New York (benzinga.com) Alexion SmartPanel Developed in Partnership With EPAM Wins Judges’ Prize in the 2018 Bio-IT World Best Practices … (globenewswire.com) Alexion SmartPanel Developed in Partnership With EPAM Wins Judges Prize in the 2018 Bio-IT World Best Practices Awards (finance.yahoo.com) Financial Review: NTT DATA Corp/ADR (NTDTY) and EPAM Systems (EPAM) (americanbankingnews.com) What is RPA? A revolution in business process automation (computerworld.com.au)

    A number of equities analysts recently commented on the company. Zacks Investment Research raised EPAM Systems from a “hold” rating to a “buy” rating and set a $132.00 price objective on the stock in a research note on Monday, April 23rd. Needham & Company LLC lifted their price objective on EPAM Systems to $130.00 and gave the stock a “buy” rating in a research note on Tuesday, February 20th. They noted that the move was a valuation call. Stifel Nicolaus reaffirmed a “buy” rating and issued a $135.00 price objective (up from $105.00) on shares of EPAM Systems in a research note on Friday, February 16th. ValuEngine raised EPAM Systems from a “hold” rating to a “buy” rating in a research note on Monday, April 2nd. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $132.00 price objective (up from $123.00) on shares of EPAM Systems in a research note on Tuesday, February 20th. Three research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $125.25.

Top 10 Gold Stocks For 2019: 21Vianet Group, Inc.(VNET)

Advisors’ Opinion:

  • [By Stephan Byrd]

    21Vianet Group (NASDAQ:VNET) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a report issued on Tuesday.

  • [By Joseph Griffin]

    21Vianet Group (NASDAQ: VNET) and 58.com (NYSE:WUBA) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations and institutional ownership.

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares climbed 31.68 percent to close at $7.19 on Wednesday. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares gained 24.15 percent to close at $3.29. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    21Vianet Group, Inc. (NASDAQ: VNET) shares surged 24 percent to close at $6.82.
    Check-Cap Ltd. (NASDAQ: CHEK) gained 20.25 percent to close at $4.87.
    HUYA Inc. (NYSE: HUYA) shares surged 18.42 percent to close at $22.50
    Abaxis, Inc. (NASDAQ: ABAX) rose 16.15 percent to close at $83.34. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Pain Therapeutics, Inc. (NASDAQ: PTIE) shares jumped 16.07 percent to close at $10.62.
    Bilibili Inc. (NASDAQ: BILI) rose 16.04 percent to close at $14.11.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) gained 14.88 percent to close at $6.33.
    Phoenix New Media Limited (NYSE: FENG) rose 13.96 percent to close at $5.55.
    Daqo New Energy Corp. (NYSE: DQ) jumped 13.88 percent to close at $67.27 on Wednesday.
    Sea Limited (NYSE: SE) jumped 12.59 percent to close at $11.98 after reporting Q1 results.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 12.01 percent to close at $5.13.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) gained 11.93 percent to close at $3.19.
    Boot Barn Holdings, Inc. (NYSE: BOOT) climbed 11.66 percent to close at $24.52 on Wednesday after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Macy's, Inc. (NYSE: M) rose 10.83 percent to close at $33.17 after the company reported stronger-than-expected results for its first quarter and lifted guidance.
    ChemoCentryx, Inc. (NASDAQ: CCXI) gained 9.36 percent to close at $12.50. Canaccord Genuity initiated coverage on ChemoCentryx with a Buy rating.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX)
  • [By Lisa Levin] Gainers
    SenesTech, Inc. (NASDAQ: SNES) shares jumped 113.5 percent to $0.6737 after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California.
    AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares rose 35.34 percent to close at $3.32.
    Art's-Way Manufacturing Co., Inc. (NASDAQ: ARTW) shares gained 30.36 percent to $3.65.
    Xtant Medical Holdings, Inc. (NYSE: XTNT) shares jumped 25.6 percent to $7.4701 after the company disclosed that it has received the FDA clearance for InTice™-C Porous Titanium Cervical Interbody System.
    VAALCO Energy, Inc. (NYSE: EGY) shares surged 20 percent to $2.495.
    TransGlobe Energy Corporation (NASDAQ: TGA) surged 17.04 percent to $2.61.
    Boxlight Corporation (NASDAQ: BOXL) gained 15 percent to $8.32 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the development of next generation interactive educational activities.
    Arcimoto, Inc. (NASDAQ: FUV) gained 15 percent to $3.39.
    MB Financial, Inc. (NASDAQ: MBFI) rose 13.7 percent to $49.64. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    FRONTEO, Inc. (NASDAQ: FTEO) shares rose 11.8 percent to $20.956.
    TransEnterix, Inc. (NYSE: TRXC) shares jumped 11.1 percent to $3.38.
    21Vianet Group, Inc. (NASDAQ: VNET) rose 10.6 percent to $7.41.
    NII Holdings, Inc. (NASDAQ: NIHD) shares gained 9 percent to $2.32.
    Kelly Services, Inc. (NASDAQ: KELYA) rose 7.6 percent to $24.19. Northcoast Research upgraded Kelly Services from Neutral to Buy.
    LaSalle Hotel Properties (NYSE: LHO) shares climbed 5.6 percent to $33.70. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Alteryx, Inc. (NYSE: AYX) gained 5.5 percent to $32.56. KeyBanc upgraded Alteryx from Sector Weight to Overweight.
    Energizer Holdings, Inc. (NYSE:
  • [By Lisa Levin] Gainers
    SenesTech, Inc. (NASDAQ: SNES) shares surged 296.07 percent to close at $1.25 on Monday after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California.
    AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares gained 19.59 percent to close at $2.93.
    TransGlobe Energy Corporation (NASDAQ: TGA) rose 18.39 percent to close at $2.64 on Monday.
    Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) shares gained 15.91 percent to close at $2.55.
    VAALCO Energy, Inc. (NYSE: EGY) shares jumped 14.9 percent to close at $2.39.
    Resonant Inc. (NASDAQ: RESN) climbed 13.96 percent to close at $4.49.
    Chesapeake Energy Corporation (NYSE: CHK) shares rose 13.55 percent to close at $4.61 on Monday.
    Lilis Energy, Inc. (NYSE: LLEX) surged 13.09 percent to close at $5.01.
    MB Financial, Inc. (NASDAQ: MBFI) gained 12.9 percent to close at $49.28. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 12.83 percent to close at $3.43.
    World Wrestling Entertainment, Inc. (NYSE: WWE) jumped 12.52 percent to close at $57.86 on Reports that it has reached a deal with Fox for Its 'Smackdown Live' program.
    Eastman Kodak Company (NASDAQ: KODK) rose 12.38 percent to close at $5.90.
    NuCana plc (NASDAQ: NCNA) climbed 11.94 percent to close at $26.44. NuCana appointed Dr. Cyrille Leperlier to its Board as an independent non-executive Director.
    Aqua Metals, Inc. (NASDAQ: AQMS) rose 11.83 percent to close at $3.97 on Monday.
    Huami Corporation (NYSE: HMI) shares jumped 11.27 percent to close at $10.17 following Q1 results.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 9.55 percent to close at $7.34.
    Boxlight Corporation (NASDAQ: BOXL) rose 8.56 percent to close at $7.86 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the de

Top 10 Gold Stocks For 2019: Sanderson Farms Inc.(SAFM)

Advisors’ Opinion:

  • [By Logan Wallace]

    ValuEngine cut shares of Sanderson Farms (NASDAQ:SAFM) from a strong-buy rating to a buy rating in a research report released on Wednesday morning.

  • [By Ethan Ryder]

    Shares of Sanderson Farms, Inc. (NASDAQ:SAFM) have been assigned an average rating of “Hold” from the thirteen brokerages that are currently covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $111.75.

  • [By Lisa Levin]

    Tuesday morning, the consumer staples shares surged 0.17 percent. Meanwhile, top gainers in the sector included CV Sciences, Inc. (OTC: CVSI), up 6 percent, and Sanderson Farms, Inc. (NASDAQ: SAFM) up 5 percent.

  • [By Stephan Byrd]

    Federated Investors Inc. PA cut its position in Sanderson Farms, Inc. (NASDAQ:SAFM) by 71.5% in the first quarter, HoldingsChannel reports. The firm owned 20,286 shares of the company’s stock after selling 51,010 shares during the quarter. Federated Investors Inc. PA’s holdings in Sanderson Farms were worth $2,415,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Shares of Sanderson Farms, Inc. (NASDAQ:SAFM) have been given a consensus recommendation of “Hold” by the thirteen research firms that are covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $111.75.

Top 10 Gold Stocks For 2019: Sun Life Financial Inc.(SLF)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Sentry Investments Corp. grew its holdings in Sun Life Financial (NYSE:SLF) (TSE:SLF) by 2.3% in the first quarter, HoldingsChannel reports. The institutional investor owned 531,100 shares of the financial services provider’s stock after buying an additional 11,900 shares during the quarter. Sentry Investments Corp.’s holdings in Sun Life Financial were worth $28,101,000 at the end of the most recent reporting period.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
    Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
    The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
    Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
    Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
    LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
    Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
    TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
    The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
    A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
    Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
    Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
    ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
    KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

  • [By Max Byerly]

    Sun Life Financial (NYSE: SLF) and Scor (OTCMKTS:SCRYY) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Top 10 Gold Stocks For 2019: Citizens Financial Group, Inc.(CFG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Citizens Financial Group Inc (NYSE:CFG) insider Randall J. Black sold 792 shares of Citizens Financial Group stock in a transaction on Tuesday, June 5th. The shares were sold at an average price of $41.49, for a total value of $32,860.08. Following the completion of the transaction, the insider now owns 34,258 shares in the company, valued at $1,421,364.42. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Citizens Financial Group (CFG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shanthi Rexaline]

    Citizens Financial Group Inc (NYSE: CFG) shares were down Tuesday, dragged by macro concerns following the rise in Italian sovereign debt yields and a 14-basis point decline in the 10-year U.S. treasury yield.

  • [By Max Byerly]

    M&T Bank Corp lowered its stake in Citizens Financial Group (NYSE:CFG) by 38.5% during the 1st quarter, HoldingsChannel reports. The firm owned 52,349 shares of the bank’s stock after selling 32,830 shares during the quarter. M&T Bank Corp’s holdings in Citizens Financial Group were worth $2,198,000 at the end of the most recent reporting period.

Top 10 Gold Stocks For 2019: AxoGen, Inc.(AXGN)

Advisors’ Opinion:

  • [By Shane Hupp]

    AxoGen, Inc (NASDAQ:AXGN) – Analysts at William Blair raised their Q2 2018 earnings estimates for AxoGen in a research report issued on Monday, May 14th. William Blair analyst K. Krum now expects that the medical equipment provider will post earnings per share of ($0.04) for the quarter, up from their prior forecast of ($0.05). William Blair currently has a “Outperform” rating on the stock. William Blair also issued estimates for AxoGen’s Q4 2018 earnings at ($0.03) EPS and FY2018 earnings at ($0.25) EPS.

  • [By Lee Jackson]

    Jefferies started coverage on this top biotech/medtech firm last year with a Buy rating. AxoGen Inc. (NASDAQ: AXGN) offers surgical solutions for peripheral nerve injuries. It provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane.

  • [By Joseph Griffin]

    These are some of the media stories that may have impacted Accern’s analysis:

    Get AxoGen alerts:

    Analysts Anticipate AxoGen, Inc (AXGN) Will Announce Earnings of -$0.06 Per Share (americanbankingnews.com) The SVP Sales of AxoGen (NASDAQ: AXGN) is Selling Shares (analystratings.com) BRIEF-Axogen Inc Says On May 15, Board Elected CEO Zaderej To Succeed Grooms As Chairman (reuters.com) AxoGen, Inc (AXGN) SVP Shawn F. Mccarrey Sells 10,000 Shares (americanbankingnews.com) Global Nerve Repair Biomateria Market Report 2018-2023 -Axogen, Integra, Synovis, Collagen Matrix, Polyganics … (talkdailynews.com)

    AxoGen opened at $43.95 on Monday, Marketbeat reports. AxoGen has a fifty-two week low of $13.95 and a fifty-two week high of $46.00. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.81 and a current ratio of 3.32. The company has a market cap of $1.52 billion, a P/E ratio of -141.77 and a beta of -0.04.

  • [By Lee Jackson]

    This is another biotech/medical technology that Jefferies started coverage on with a Buy rating late last year. AxoGen Inc. (NASDAQ: AXGN) offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane.

Top 10 Gold Stocks For 2019: Landstar System, Inc.(LSTR)

Advisors’ Opinion:

  • [By Asit Sharma]

    Jacksonville, Florida-based third-party logistics (3PL) providerLandstar System, Inc. (NASDAQ:LSTR) enjoyed record revenue in the first quarter of 2018. The handsome $1.05 billion top line was accompanied by record quarterlygross profit of $155.5 million. Investors have applauded the performance: Though volatile, Landstar’s stock has gained nearly 9% year to date, and over a 12-month period, the LSTR symbol has returned nearly 29%. As we look ahead to second-quarter results, which will be reported next month, can the Landstar maintain the vigorous earnings momentum that has supported its stock price ascent?

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Landstar System (LSTR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Landstar System (NASDAQ: LSTR) and YRC Worldwide (NASDAQ:YRCW) are both transportation companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Landstar System (LSTR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Gold Stocks For 2019: Sonic Corp.(SONC)

Advisors’ Opinion:

  • [By Max Byerly]

    SG Americas Securities LLC raised its stake in Sonic Drive-In (NASDAQ:SONC) by 70.9% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,285 shares of the restaurant operator’s stock after buying an additional 2,608 shares during the quarter. SG Americas Securities LLC’s holdings in Sonic Drive-In were worth $159,000 at the end of the most recent quarter.

  • [By Jeremy Bowman]

    Shares ofSonic Corporation(NASDAQ:SONC) were flying higher today after the fast-food, drive-up chain reported preliminary third-quarter results and said it would increase share buybacks. The stock rose throughout the day and closed up 16.4%.

  • [By Stephan Byrd]

    Darden Restaurants (NYSE: DRI) and Sonic Drive-In (NASDAQ:SONC) are both retail/wholesale companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, institutional ownership and valuation.

  • [By Leo Sun]

    Shares of Sonic (NASDAQ:SONC) tumbled 5% onJune 27, after the fast-food chain posted mixed third-quarter numbers. Its revenue fell 5% year over year to $118.3 million, which missed expectations by $0.35 million and marked its eighth straight quarter of declining sales.

  • [By Logan Wallace]

    Sonic Drive-In (NASDAQ:SONC) was downgraded by equities research analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued to investors on Wednesday.

  • [By Logan Wallace]

    ValuEngine upgraded shares of Sonic Drive-In (NASDAQ:SONC) from a sell rating to a hold rating in a report issued on Thursday morning.

    Several other equities research analysts have also recently commented on the company. Barclays cut their price target on Sonic Drive-In from $28.00 to $25.00 and set an underweight rating for the company in a report on Wednesday, March 28th. Zacks Investment Research cut Sonic Drive-In from a buy rating to a hold rating in a report on Thursday, March 15th. BidaskClub raised Sonic Drive-In from a sell rating to a hold rating in a report on Tuesday, March 20th. Cowen cut their price target on Sonic Drive-In from $29.00 to $28.00 and set a market perform rating for the company in a report on Wednesday, March 28th. Finally, Morgan Stanley cut their price target on Sonic Drive-In from $29.00 to $28.00 and set an equal weight rating for the company in a report on Monday, March 26th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and five have issued a buy rating to the company’s stock. The stock presently has an average rating of Hold and a consensus target price of $28.67.

Crispr Therapeutics: Assessing The Recent Capital Financing

The reason why the growth stocks do so much better is that they seem to show gains in value in the hundreds of percent each decade. In contrast, it is an unusual bargain that is as much as 50 percent undervalued. The cumulative effect of this simple arithmetic should be obvious. – Philip Fisher (the Father of Growth Investing)

On Jan 05, 2018, the share price of Crispr Therapeutics (NASDAQ:CRSP), a bioscience focusing on gene-editing and CAR-T to treat serious conditions such as cancers and genetic diseases, continued its rally. The stock added another $2.90 (over 12% profits) to value at $26.81 for the said trading session. Since we recommended the company on Nov. 27, 2017 (just over a month) to subscribers of Integrated BioSci Investing, the stock added another $7.26 (or 37% in capital appreciation). This robust run-up is interesting because, on Jan. 04, 2018, the company announced that the 5M additional common shares issued on Jan 03 will be priced at $22.75.

Figure 1: Crispr stock chart. (Source: Stockcharts).

At Integrated BioSci Investing (IBI), we have much success in finding robust performers. For instance, Nektar Therapeutics (NASDAQ:NKTR) appreciated over 200% for subscribers. Exelixis Inc procured over 50% profits. In this report, we’ll assess the ramifications of the recent financing and to reaffirm the investment thesis on Crispr.

Fundamentals Analysis

Back in 2017, there were several stellar medical breakthroughs that have ramifications that can be as far reaching as the introduction of chemotherapy more than a decade prior. Accordingly, the US FDA approved Yescarta (a CAR-T indicated for the treatment of non-Hodgkin lymphoma). The said molecule was innovated by Kite Pharma (NASDAQ:KITE) – a firm acquired by Gilead Sciences(NASDAQ:GILD). Moreover, the agency also approved the first gene therapy, Luxturna (voretigene neparvovec-rzyl), a molecule innovated by Sparks Therapeutics (NASDAQ:ONCE). It is a one-time treatment for patients afflicted with biallelic RPE65 mutation-associated retinal dystrophy.

In the midst of the aforesaid favorable regulatory environment for medical breakthroughs, the Switzerland-based company, Crispr Therapeutics is also brewing a revolutionary method of treating cancers and rare genetic diseases. As follows, CRISPR/Cas9 is a form of gene-editing currently being investigated in various conditions (as shown in the enriched pipeline in figure 2). The company also has a gene-editing enhanced form of CAR-T in development for various cancers. Of most interest is the lead molecule, CTX-001 (also a gene-editing therapeutic) that can be potentially used for the management of serious blood disorders: beta-thalassemia and sickle cell disease (SCD).

Figure 2: Therapeutic pipeline. (Source: Crispr).

Final Remarks

As alluded, Crispr recently issued another 5M common shares at the price of $22.75. The company also granted the underwriters a 30-day option to purchase up to 750K of its common shares. The expected gross proceeds from this offering are roughly $113.75M (excluding any exercise of the underwriters option to purchase additional shares). Moreover, the offering is expected to close on Jan. 09. The company employed Goldman Sachs (NYSE:GS), Piper Jaffray (NYSE:PJC), Barclays Capital (NYSE:BCS), and Guggenheim Securities as joint book-running managers for the said offerings. We strongly believe that the aforesaid capital financing is both strategic and prudent, as substantial capital (in the ballpark of over a billion dollars) is needed to fund a molecule from bench research to commercialization. With the share price appreciating, it is wise that the firm issued new shares to strengthen its capital for further pipeline innovation. There is an in-depth Integrated BioSci version of this research, which is available in advanced to subscribers of Integrated BioSci Investing.

Authors Notes: Were honored that you took the time out of your busy day to read our market intelligence. Founded by Dr. Hung Tran, MD, MS, CNPR, (in collaborations with Dr. Tran BioSci analyst, Ngoc Vu, and other PhDs), Integrated BioSci Investing (IBI) marketplace research is delivering stellar returns since inceptions. To name a few, Nektar Therapeutics (NASDAQ:NKTR) procured more than 210% profits; Spectrum Pharmaceuticals (NASDAQ:SPPI) delivered over 180% gains; Kite Pharma netted 82%. Exelixis Inc (NASDAQ:EXEL) earned greater than 50% capital appreciation. Our secret sauce is extreme due diligence coupled with expert data analysis. The service features a once-weekly exclusive in-depth Integrated BioSci Alpha-Intelligence article (in the form of research, reports, or interviews), daily individual stocks consulting, and model portfolios.

Notably, well increase our price soon. SUBSCRIBE to our marketplace research now to lock in the legacy price and save money in the future. To receive real-time alerts on our articles as well as blogs, be sure to check out our profile page and CLICK the orange FOLLOW button . Asides the exclusivities, this article is the truncated version of the research we published in advance to IBI subscribers. Further, you can read up on Dr. Trans background by following this link.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

About this article:ExpandAuthor payment: Seeking Alpha pays for exclusive articles. Payment calculations are based on a combination of coverage area, popularity and quality.Tagged: Investing Ideas, Long Ideas, Healthcare, Biotechnology, SwitzerlandWant to share your opinion on this article? Add a comment.Disagree with this article? Submit your own.To report a factual error in this article, click here